ATE204336T1 - Verbesserte methode zur selektion spezifischer bakteriophagen - Google Patents
Verbesserte methode zur selektion spezifischer bakteriophagenInfo
- Publication number
- ATE204336T1 ATE204336T1 AT96901168T AT96901168T ATE204336T1 AT E204336 T1 ATE204336 T1 AT E204336T1 AT 96901168 T AT96901168 T AT 96901168T AT 96901168 T AT96901168 T AT 96901168T AT E204336 T1 ATE204336 T1 AT E204336T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- improved method
- phage
- sec
- molecule
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 241001515965 unidentified phage Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 101710094648 Coat protein Proteins 0.000 abstract 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 101710141454 Nucleoprotein Proteins 0.000 abstract 1
- 101710083689 Probable capsid protein Proteins 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9500851.2A GB9500851D0 (en) | 1995-01-17 | 1995-01-17 | Method of selecting specific bacteriophages |
| PCT/SE1996/000030 WO1996022393A1 (en) | 1995-01-17 | 1996-01-15 | Improved method of selecting specific bacteriophages |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE204336T1 true ATE204336T1 (de) | 2001-09-15 |
Family
ID=10768125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96901168T ATE204336T1 (de) | 1995-01-17 | 1996-01-15 | Verbesserte methode zur selektion spezifischer bakteriophagen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6027930A (de) |
| EP (1) | EP0805877B1 (de) |
| JP (1) | JPH11503001A (de) |
| AT (1) | ATE204336T1 (de) |
| AU (1) | AU705802B2 (de) |
| CA (1) | CA2210567A1 (de) |
| DE (1) | DE69614510T2 (de) |
| GB (1) | GB9500851D0 (de) |
| WO (1) | WO1996022393A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2095633C (en) * | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| GB9716900D0 (en) * | 1997-08-08 | 1997-10-15 | Bioinvent Int Ab | Method for selecting phage displaying ligand binders |
| JP4327350B2 (ja) * | 1997-11-17 | 2009-09-09 | マイクロメット アーゲー | エピトープへの結合能力を保持する結合部位ドメインの同定のための新規方法 |
| JP2002522029A (ja) | 1998-07-27 | 2002-07-23 | ジェネンテック・インコーポレーテッド | コートタンパク質の改変によるファージ提示における改良した形質転換効率 |
| WO2000066155A1 (en) | 1999-04-30 | 2000-11-09 | La Jolla Institute For Allergy And Immunology | Methods for preventing reactivation of latent virus and controlling virus replication |
| US6472147B1 (en) | 1999-05-25 | 2002-10-29 | The Scripps Research Institute | Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| US7070926B2 (en) * | 2001-06-15 | 2006-07-04 | Crucell Holland B.V. | Chimaeric phages |
| ES2257560T3 (es) * | 2001-06-15 | 2006-08-01 | Crucell Holland B.V. | Fagos quimericos. |
| WO2003008564A2 (en) * | 2001-07-18 | 2003-01-30 | Instytut Immunologii I Terapii Doswiadczalnej Pan | Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| KR100458083B1 (ko) * | 2001-08-29 | 2004-11-18 | 주식회사 아이지세라피 | 파아지 디스플레이 라이브러리로부터 특정 이종 단백질의효율적인 분리를 위한 개선된 헬퍼 파아지 시스템 |
| US7175983B2 (en) * | 2001-11-02 | 2007-02-13 | Abmaxis, Inc. | Adapter-directed display systems |
| DE10238846A1 (de) * | 2002-08-20 | 2004-03-04 | Nemod Immuntherapie Ag | Aktive Fusionsproteine und Verfahren zu ihrer Herstellung |
| PT2271670E (pt) | 2008-03-14 | 2014-11-28 | Allergan Inc | Ensaio imunobaseado da atividade do serotipo a da toxina botulínica |
| PL215522B1 (pl) | 2008-09-29 | 2013-12-31 | Inst Immunologii I Terapii Doswiadczalnej Pan | Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus |
| KR101923847B1 (ko) | 2009-03-13 | 2018-11-29 | 알러간, 인코포레이티드 | 면역 기반 재표적화된 엔도펩티다제 활성 검정 |
| PL212258B1 (pl) | 2010-06-20 | 2012-09-28 | Inst Immunologii I Terapii Doswiadczalnej Pan | Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas |
| WO2014150870A2 (en) | 2013-03-15 | 2014-09-25 | Altria Client Services Inc. | Bacteriophage and methods of making and using |
| EP3077417A1 (de) | 2013-12-08 | 2016-10-12 | Peptcell Limited | Hiv-antigene und antikörper und zusammensetzungen, verfahren und verwendungen davon |
| US9781929B2 (en) | 2015-01-29 | 2017-10-10 | Altria Client Services Llc | Bacteriophage and methods of using |
| US10357056B2 (en) | 2015-01-29 | 2019-07-23 | Altria Client Services Llc | Endolysin from bacteriophage against Geobacillus and methods of using |
| EP3312290A1 (de) | 2016-10-18 | 2018-04-25 | Ipsen Biopharm Limited | Zellulärer vamp-spaltungstest |
| WO2019017967A1 (en) * | 2017-07-21 | 2019-01-24 | Angela Belcher | MODIFIED BACTERIOPHAGE SYSTEMS |
| US10987388B2 (en) | 2017-07-21 | 2021-04-27 | Massachusetts Institute Of Technology | Homogeneous engineered phage populations |
| EP3692370A2 (de) | 2017-10-04 | 2020-08-12 | OPKO Pharmaceuticals, LLC | Artikel und verfahren zur personalisierten krebstherapie |
| CN113388585B (zh) * | 2021-06-10 | 2024-05-14 | 江苏农牧科技职业学院 | 一种噬菌体高滴度培养方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0614989A1 (de) * | 1993-02-17 | 1994-09-14 | MorphoSys AG | Verfahren für in vivo Selektion von Ligandenbindende Proteine |
| SE9304060D0 (sv) * | 1993-12-06 | 1993-12-06 | Bioinvent Int Ab | Sätt att selektera specifika bakteriofager |
-
1995
- 1995-01-17 GB GBGB9500851.2A patent/GB9500851D0/en active Pending
-
1996
- 1996-01-15 CA CA002210567A patent/CA2210567A1/en not_active Abandoned
- 1996-01-15 JP JP8522196A patent/JPH11503001A/ja not_active Ceased
- 1996-01-15 DE DE69614510T patent/DE69614510T2/de not_active Expired - Lifetime
- 1996-01-15 AT AT96901168T patent/ATE204336T1/de not_active IP Right Cessation
- 1996-01-15 WO PCT/SE1996/000030 patent/WO1996022393A1/en not_active Ceased
- 1996-01-15 US US08/875,069 patent/US6027930A/en not_active Expired - Lifetime
- 1996-01-15 EP EP96901168A patent/EP0805877B1/de not_active Expired - Lifetime
- 1996-01-15 AU AU44992/96A patent/AU705802B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0805877A1 (de) | 1997-11-12 |
| DE69614510D1 (de) | 2001-09-20 |
| AU4499296A (en) | 1996-08-07 |
| US6027930A (en) | 2000-02-22 |
| EP0805877B1 (de) | 2001-08-16 |
| CA2210567A1 (en) | 1996-07-25 |
| GB9500851D0 (en) | 1995-03-08 |
| JPH11503001A (ja) | 1999-03-23 |
| AU705802B2 (en) | 1999-06-03 |
| WO1996022393A1 (en) | 1996-07-25 |
| DE69614510T2 (de) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE204336T1 (de) | Verbesserte methode zur selektion spezifischer bakteriophagen | |
| DE69417446D1 (de) | Methode zur selektion spezifischer bakteriophagen | |
| HUP0100094A1 (hu) | Új felületi antigén | |
| US5985588A (en) | Phagemid for antibody screening | |
| Samson | The suicidal DNA repalr methyltransferases of microbes | |
| CA2365898A1 (en) | Ibd-associated microbial antigens and methods of using same | |
| DE69941701D1 (de) | Mutanten von flt3-l und ihre verwendungen | |
| NZ502391A (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| WO1995034683A1 (en) | Method of detecting compounds utilizing genetically modified lambdoid bacteriophage | |
| ITRM930301A1 (it) | Procedimento per la preparazione di immunogeni e reagenti diagnostici, e immunogeni e reagenti diagnostici cosi' ottenibili. | |
| DK0886644T3 (da) | Lang bölgelængde-modificerede fluorescerende proteiner | |
| ATE293690T1 (de) | Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie | |
| HUP0002474A2 (hu) | Javított anti-IgE antitestek és eljárások polipeptidek kötődési tulajdonságainak javítására | |
| Kretzschmar et al. | Selection procedures for nonmatured phage antibodies: a quantitative comparison and optimization strategies | |
| WO2001032882A3 (en) | Nucleic acids and proteins from group b streptococcus | |
| ATE266091T1 (de) | Rekombinante phagen | |
| ES2100340T3 (es) | Antigeno peptidico de cdw52 sintetico (campath-1). | |
| ZA962813B (en) | Polypeptides having a functional domain of interest and method of identifying and using same | |
| DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
| US5663069A (en) | Modified lambda bacteriophage | |
| MY126769A (en) | Dna sequence encoding the specific and antigenic outer membrane protein of salmonella typhi | |
| WO1999007842A1 (en) | Materials and methods for selecting phage displaying ligand binders | |
| Xylouri-Frangiadaki et al. | Antibody level of Infectious Bursal Disease (IBD) in layers | |
| ATE385573T1 (de) | Verfahren zum identifizieren von liganden der rna-polymerase sigma 70 untereinheit | |
| CA2262500A1 (en) | Measles virus mutant antigen and gene coding for the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |